PLA2G7 and Alzheimer disease: Both Lp-PLA2 activity and mass [51] and MR-proADM [52] have previously been established as biomarkers of future AAA hospitalization in MDCS subjects, but in these previous reports, AAA incidence was not evaluated as isolated AAA without concomitant AD.